Purchase Order 75F40118P10231
Award Date 8/14/18
Potential Completion Date 8/13/19
Potential Value $153K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $114,681.00 contract is for the delivery of a MiSeq System, a high-throughput next-generation DNA sequencing platform used to support life science research, applied markets, and molecular diagnostics. This award does not have a set-aside designation. Illumina has a history of providing...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the delivery of 3 Illumina MiSeq sequencing systems. The $284,971.50 contract has an April 30, 2019 completion date and does not use any set-aside provisions. Illumina has a history of providing sequencing equipment and consumables to support genomic research and diagnostics at various federal...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- The Department of Health and Human Services Food and Drug Administration awarded a $136,975.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for MiSeq sequencing service agreements covering four instruments, with a performance period ending on March 8, 2023. Illumina has previously received prime federal awards from agencies like the National Institutes of Health and Department of Veterans...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $212,705.80 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The purchase order is for Illumina MiSeq service contracts to support the FDA's microbial genomics program, which requires the maintenance of 10 MiSeq sequencing instruments to perform bacterial foodborne pathogen genome sequencing, targeted gene sequencing, and...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $98,736.56 contract is for the provision of MISEQ REAGENT KITS to support the agency's genetic and genomic analysis requirements. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the NIH, CDC, USDA, and VA, to supply sequencing...
- This $81,810 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq instrument and does not have a set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the provision of MiSeq sequencing systems and reagent kits, with a ceiling value of $291,742.95 and a completion date of September 13, 2017. The contract was not set aside for any specific business category. Illumina has previously been awarded prime federal contracts and subcontracts by agencies...
- The Department of Health and Human Services' Food and Drug Administration awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide a MiSeq System for $95,931.00. The MiSeq System is an integrated system for automated generation of DNA clonal clusters, sequencing, and primary and secondary analysis. The award was made on February 28, 2020 with a completion date of March 12, 2021. There was no set-aside used for this...